Breaking Update
Aidoc’s Israeli AI Receives FDA Approval to Speed Emergency Care
Aidoc's Israeli AI receives FDA clearance for a multi-condition solution, speeding up emergency care by analyzing over 100 million patient cases and improving.
Jerusalem, 21 January, 2026 (TPS-IL) — Aidoc, a Tel Aviv-based medical AI company, has received FDA clearance for the first clinical AI that can handle multiple acute conditions at once. The solution combines 11 new and three existing indications, helping hospitals spot critical findings faster, ease imaging backlogs, and improve patient flow in busy emergency departments. Built on Aidoc’s aiOS platform, which has analyzed over 100 million patient cases, the system reduces false alerts while supporting real-world clinical use.
CEO Elad Walach said the approval “marks a new era for clinical AI.”
